Johannes A. Kroes

Leeuwarden, FR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Attitudes and Practices Regarding Dosing Interval Extension of Biologics in Severe Asthma: A Nationwide Survey and Real-World Data From the Dutch RAPSODI Registry.

Attitudes and Practices Regarding Dosing Interval Extension of Biologics in Severe Asthma: A Nationwide Survey and Real-World Data From the Dutch RAPSODI Registry.

Journal: The journal of allergy and clinical immunology. In practice

Published: November 25, 2025

Paracetamol Half-Life Declines over Time After an Acute Overdose.

Paracetamol Half-Life Declines over Time After an Acute Overdose.

Journal: Therapeutic drug monitoring

Published: May 14, 2025

Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity.

Impact of Dupilumab for Severe Asthma on Fatigue, Quality of Life, Work Productivity, and Activity.

Journal: The journal of allergy and clinical immunology. In practice

Published: April 30, 2025

Upadacitinib Optimization in a Patient With Protein-Losing Enteropathy Secondary to (Transient) Nonocclusive Mesenteric Ischemia, Idiopathic Myointimal Hyperplasia, and Hemodialysis.

Upadacitinib Optimization in a Patient With Protein-Losing Enteropathy Secondary to (Transient) Nonocclusive Mesenteric Ischemia, Idiopathic Myointimal Hyperplasia, and Hemodialysis.

Journal: Therapeutic drug monitoring

Published: November 20, 2024

Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report.

Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report.

Journal: European journal of hospital pharmacy : science and practice

Published: May 05, 2024

Delayed cardiac arrest after hydrofluoric acid ingestion.

Delayed cardiac arrest after hydrofluoric acid ingestion.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: March 19, 2024

Long-Term Weight Changes After Starting Anti-IL-5/5Ra Biologics in Severe Asthma: The Role of Oral Corticosteroids.

Long-Term Weight Changes After Starting Anti-IL-5/5Ra Biologics in Severe Asthma: The Role of Oral Corticosteroids.

Journal: The journal of allergy and clinical immunology. In practice

Published: April 14, 2023

The perceived waning of biologics in severe asthma.

The perceived waning of biologics in severe asthma.

Journal: Respiratory medicine

Published: April 07, 2023

Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.

Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.

Journal: ERJ open research

Published: January 03, 2023

Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis.

Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 02, 2022

Characteristics of severe asthma patients on biologics: a real-life European registry study.

Characteristics of severe asthma patients on biologics: a real-life European registry study.

Journal: ERJ open research

Published: November 02, 2022

Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics.

Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics.

Journal: ERJ open research

Published: October 22, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026